REGN - Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc Logo

REGN - Regeneron Pharmaceuticals Inc

https://www.regeneron.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.

52W High
$1165.58
52W Low
$475.77
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.35
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
14.45
Forward P/E (<15 better)
14.77
EV/EBITDA (<8 favorable)
10.33
EV/Revenue (<3 favorable)
3.94
P/S (TTM) (<3 favorable)
4.28
P/B (<3 favorable)
2.03
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
1.94%
Institutions (25–75% balanced)
90.25%
Shares Outstanding
104,170,000
Float
97,886,000
Dividend Yield (2–6% sweet spot)
0.00%
Ex‑Dividend Date
2025-08-18
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
14,214,200,000
Gross Profit (TTM)
6,730,500,000
EPS (TTM)
39.68
Profit Margin (>10% good)
0.31%
Operating Margin (TTM) (higher better)
0.30%
ROE (TTM) (>15% strong)
0.15%
EPS YoY (Quarterly) (>10% good)
0.03
Revenue YoY (Quarterly) (>8% good)
0.04
Momentum
Bearish momentum
Value
-1.7147
Previous
-1.0425
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025